Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diffuse Parenchymal Lung Diseases”

1,630 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,630 results

Testing effectiveness (Phase 2)Ended earlyNCT03562416
What this trial is testing

Continuation of Nintedanib After Single Lung Transplantation in IPF Subjects

Who this might be right for
Idiopathic Pulmonary FibrosisLung Transplant; Complications
Temple University 1
Not applicableStudy completedNCT03898284
What this trial is testing

Impulse Oscillometry for Prognostication in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
University Hospital, Tours 54
Not applicableLooking for participantsNCT05854563
What this trial is testing

Cough Capture as a Portal Into the Lung

Who this might be right for
Lung DiseasesLung CancerLung Diseases, Obstructive+2 more
Albert Einstein College of Medicine 2,000
Not applicableStudy completedNCT05670587
What this trial is testing

A Study in People With Pulmonary Fibrosis to Monitor Cough With a Wearable Device

Who this might be right for
Pulmonary Fibrosis
Boehringer Ingelheim 53
Testing effectiveness (Phase 2)UnknownNCT05246293
What this trial is testing

Tofacitinib in the Treatment of Rheumatoid Arthritis-related Interstitial Lung Disease.

Who this might be right for
Rheumatoid ArthritisInterstitial Lung Disease
National Institute of Respiratory Diseases, Mexico 60
Not applicableStudy completedNCT04281784
What this trial is testing

Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)

Who this might be right for
DementiaChronic DiseaseNeoplasm Metastasis+8 more
University of Washington 2,512
Not applicableStudy completedNCT01600352
What this trial is testing

Specific Autoantibody Testing in Patients With Interstitial Lung Disease

Who this might be right for
Interstitial Lung Disease
Singapore General Hospital 20
Not applicableNo Longer AvailableNCT05624281
What this trial is testing

A Treatment Protocol to Support the Care of Children and Adolescents With Fibrosing Interstitial Lung Disease (ILD)

Who this might be right for
Lung Diseases, Interstitial (in Pediatric Populations)Childhood Interstitial Lung Disease (chILD)
Boehringer Ingelheim
Early research (Phase 1)Study completedNCT06746064
What this trial is testing

Investigate the Safety, Tolerability and Pharmacokinetics of Inhaled CHF10073 After Single and Multiple Doses in Healthy Volunteers and the Effect of Itraconazole on CHF10073 Exposure

Who this might be right for
Pulmonary Fibrosis
Chiesi Farmaceutici S.p.A. 155
Not applicableLooking for participantsNCT05567133
What this trial is testing

Risk Indicators of Sarcoidosis Evolution-Unified Protocol

Who this might be right for
Sarcoidosis, Pulmonary
University of California, San Francisco 200
Not applicableStudy completedNCT05714787
What this trial is testing

Opportunistic Screening for Osteoporotic Vertebral Fractures in Patients With Diffuse Interstitial Lung Disease

Who this might be right for
OsteoporosisInterstitial Lung DiseaseVertebral Fracture
Centre Hospitalier Universitaire de Nice 202
Not applicableLooking for participantsNCT06909409
What this trial is testing

D Vitamin and Alveolar Macrophages in Idiopathic Pulmonal Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
University of Aarhus 120
Not applicableNot Yet RecruitingNCT07004595
What this trial is testing

Evaluation of Frailty in Patients With Fibrosing Interstitial Lung Diseases: Prognostic and Therapeutic Impact

Who this might be right for
Sarcopenia
Nantes University Hospital 100
Not applicableStudy completedNCT06974799
What this trial is testing

Metabolomic Biomarkers Evaluation in Pulmonary Fibrosis

Who this might be right for
Pulmonary Fibrosis
University of Campania Luigi Vanvitelli 59
Testing effectiveness (Phase 2)Looking for participantsNCT04079179
What this trial is testing

Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders

Who this might be right for
Langerhan's Cell HistiocytosisJuvenile XanthogranulomaErdheim-Chester Disease+4 more
Carl Allen 90
Not applicableLooking for participantsNCT07269262
What this trial is testing

SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers

Who this might be right for
Progressive Pulmonary FibrosisInterstitial Lung Disease
Medical University of South Carolina 170
Not applicableLooking for participantsNCT00258583
What this trial is testing

Dorothy P. and Richard P. Simmons Center for ILD Research Registry

Who this might be right for
Lung Diseases, Interstitial
University of Pittsburgh 5,000
Not applicableActive Not RecruitingNCT05492994
What this trial is testing

Test Different Imaging Techniques in Patients With Different Types of Interstitial Lung Disease

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 31
Not applicableUnknownNCT04952675
What this trial is testing

Evaluation of Pneumoconiosis High Risk Early Warning Models

Who this might be right for
Pneumoconiosis
Peking University Third Hospital 200
Testing effectiveness (Phase 2)Study completedNCT00176865
What this trial is testing

Stem Cell Transplant for Immunologic or Histiocytic Disorders

Who this might be right for
Hemophagocytic LymphohistiocytosisX-Linked Lymphoproliferative DisordersChediak-Higashi Syndrome+3 more
Masonic Cancer Center, University of Minnesota 19
Load More Results